Akèy › Kansè vejik › Illinois › Joliet
Etid klinik pou Kansè vejik nan Joliet, IL
7 etid pou Kansè vejik ap chèche patisipan nan sit nan ak bò kote Joliet (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
Ap rekriteFaz 2
- Northwestern Medicine Orland Park, Orland Park · 14 mi lwen
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Ap rekriteFaz 3
- Hope and Healing Clinical Research LLC, New Lenox · 6 mi lwen
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Ap rekriteFaz 2
- UC Comprehensive Cancer Center at Silver Cross, New Lenox · 6 mi lwen
- University of Chicago Medicine-Orland Park, Orland Park · 14 mi lwen
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
Ap rekriteFaz 3
- Northwestern Medicine Orland Park, Orland Park · 14 mi lwen
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Ap rekriteFaz 2
- University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox · 6 mi lwen
- The University of Chicago Medicine Center for Advanced Care Orland Park, Orland Park · 14 mi lwen
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Ap rekriteFaz 1
- University of Chicago Comprehensive Cancer Center at Silver Cross Hospital, New Lenox · 6 mi lwen
- The University of Chicago Medicine Center for Advanced Care Orland Park, Orland Park · 14 mi lwen
Pemetrexed Response in Relation to Tumor Alterations of Gene Status for the Treatment of Patients With Metastatic Urothelial Bladder Cancer and Other Solid Tumors
Ap rekriteFaz 2
- Northwestern Medicine Orland Park, Orland Park · 14 mi lwen
Etid Kansè vejik nan lòt vil
- New York City, NY35 etid
- Nashville, TN31 etid
- Houston, TX31 etid
- Dallas, TX27 etid
- Boston, MA26 etid
- Washington, DC26 etid
- Los Angeles, CA24 etid
- Baltimore, MD24 etid
- St. Louis, MO22 etid
- Philadelphia, PA21 etid
- Seattle, WA21 etid
- Edison, NJ21 etid
Lòt etid nan Joliet
- Kansè Poumon ki pa ti selil12 etid
- Kansè poumon12 etid
- Kansè Metastatik7 etid
- Karsinòm selil skuamèz tèt ak kou6 etid
- Kansè pwostat5 etid
- Kansè Ipofaringe5 etid
- Kansè larinks5 etid
- Kansè bouch5 etid
- Leksemi mieloïd egi5 etid
- Kansè nan tete4 etid
- Kansè kolon4 etid
- Kansè renn (Kasinom selil renn)4 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.